Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy

Antonietta Gigante1, Luca Navarini2, Domenico Margiotta2

  • 1Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.

Abstract

Insights

In systemic sclerosis (SSc), elevated endostatin levels correlate with impaired kidney function and vascular damage. This suggests endostatin is a key marker for SSc-related kidney vasculopathy.

Area of Science:

  • Rheumatology
  • Nephrology
  • Vascular Biology

Background:

  • Systemic sclerosis (SSc) is characterized by impaired angiogenesis, leading to microvascular damage, poor vascular repair, and fibrosis.
  • An imbalance of pro-angiogenic and anti-angiogenic factors is implicated in SSc progression.
  • Intrarenal resistance index serves as an indicator of renal vasculopathy in SSc patients.

Purpose of the Study:

  • To investigate the levels of vascular endothelial growth factor (VEGF) and endostatin in SSc patients.
  • To correlate these angiogenic and angiostatic factors with intrarenal hemodynamic parameters, specifically the resistive index.

Main Methods:

  • Serum VEGF and endostatin levels were measured in 91 SSc patients.
  • Renal Doppler ultrasound was performed on all participants to assess intrarenal hemodynamic parameters.
  • Statistical analyses were conducted to determine correlations between serum factors and clinical/ultrasound findings.

Main Results:

  • A significant positive correlation was found between serum endostatin levels and renal Doppler parameters (p<0.0001).
  • Serum endostatin showed a negative correlation with estimated glomerular filtration rate (eGFR) (p<0.01).
  • Higher endostatin levels were observed in SSc patients with elevated resistive indices, advanced nailfold capillaroscopy damage, and digital ulcers.

Conclusions:

  • This study is the first to link intrarenal hemodynamic parameters and endostatin levels in SSc patients.
  • Endostatin emerges as a significant biomarker for scleroderma-associated vasculopathy affecting the kidneys in SSc.
  • Findings highlight the role of endostatin in the pathogenesis of renal complications in systemic sclerosis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K